Antiretroviral therapy coverage for PMTCT in Botswana

Botswana: Antiretroviral therapy coverage for PMTCT was 100.0% in 2024. ▲ Rising

Latest (2024)
100.0%
Change on year
unchanged
World rank
1st
of 84 countries
All-time high
100.0%
in 2018
All-time low
8.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Botswana, 2000–2024

0204060801002000201220242000: 8 % of pregnant women living with HIV2001: 17 % of pregnant women living with HIV2002: 25 % of pregnant women living with HIV2003: 34 % of pregnant women living with HIV2004: 43 % of pregnant women living with HIV2005: 70 % of pregnant women living with HIV2006: 82 % of pregnant women living with HIV2007: 78 % of pregnant women living with HIV2008: 79 % of pregnant women living with HIV2009: 88 % of pregnant women living with HIV2010: 79 % of pregnant women living with HIV2011: 70 % of pregnant women living with HIV2012: 89 % of pregnant women living with HIV2013: 91 % of pregnant women living with HIV2014: 84 % of pregnant women living with HIV2015: 88 % of pregnant women living with HIV2016: 87 % of pregnant women living with HIV2017: 97 % of pregnant women living with HIV2018: 100 % of pregnant women living with HIV2019: 100 % of pregnant women living with HIV2020: 100 % of pregnant women living with HIV2021: 100 % of pregnant women living with HIV2022: 100 % of pregnant women living with HIV2023: 100 % of pregnant women living with HIV2024: 100 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

In 2024, antiretroviral therapy coverage for pmtct in Botswana stood at 100.0%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 19.0% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Botswana peaked at 100.0% in 2018 and was at its lowest, 8.0%, in 2000.

Botswana ranks 1st of 84 countries on this measure, in the top 10%.

The long-run direction has been consistently rising across the 25 years of available data.

Antiretroviral therapy coverage for PMTCT in Botswana, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Botswana, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 8.0%
2001 17.0% +112.5%
2002 25.0% +47.1%
2003 34.0% +36.0%
2004 43.0% +26.5%
2005 70.0% +62.8%
2006 82.0% +17.1%
2007 78.0% -4.9%
2008 79.0% +1.3%
2009 88.0% +11.4%
2010 79.0% -10.2%
2011 70.0% -11.4%
2012 89.0% +27.1%
2013 91.0% +2.2%
2014 84.0% -7.7%
2015 88.0% +4.8%
2016 87.0% -1.1%
2017 97.0% +11.5%
2018 100.0% +3.1%
2019 100.0% +0.0%
2020 100.0% +0.0%
2021 100.0% +0.0%
2022 100.0% +0.0%
2023 100.0% +0.0%
2024 100.0% +0.0%

Botswana compared with similar countries

  • Botswana's 100.0% is above the median for upper middle income countries, which is 79.5%, 1.3× the median. (22 countries reporting)
  • Botswana's 100.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.2× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Botswana changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2001 +112.5% 8.0% 17.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 52.4% 8.0% 88.0% 10
2010s 88.5% 70.0% 100.0% 10
2020s 100.0% 100.0% 100.0% 5

Countries ranked near Botswana

  1. 1 Eswatini 100.0% compare
  2. 1 Ireland 100.0% compare
  3. 1 Uganda 100.0% compare

See the full ranking of 99 places →

More health data for Botswana

All data for Botswana →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Botswana?
Antiretroviral therapy coverage for pmtct in Botswana was 100.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Botswana?
The highest recorded value was 100.0% in 2018.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Botswana?
The lowest recorded value was 8.0% in 2000.
How does Botswana rank for antiretroviral therapy coverage for pmtct?
Botswana ranks 1st out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Botswana?
Over the last ten years it is up 19.0%. The long-run trend across the full record is rising.
Where does this Botswana data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Botswana. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/botswana/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/botswana/">Antiretroviral therapy coverage for PMTCT in Botswana</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).